DxLab Inc.

DxLab Inc.

Private
Somerville, MassachusettsHealthcare & Life Scienceshttps://dxlab.bio/

Last Round

Accelerator

Sep 23, 2024

Total Funding Raised

$5.25M

Momentum Score

25 /100

Company Overview

DxLab Inc. is a biotechnology company that develops and commercializes point-of-care diagnostic solutions for rapid, on-site detection of dangerous pathogens.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

point-of-care testingPOC testingmolecular diagnosticsinfectious disease diagnosticsrapid diagnosticsportable testing systemsample-to-answerrazor and blade modelLAMP technologydiagnostic reagentsassay developmentpublic health surveillanceemergency use authorizationEUA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DxLab Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DxLab Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 23, 2024
GrantJun 7, 2024
SeedDec 23, 2020

Key People

Founding team and executive leadership

Hojun Suk

Co-Founder & CEO

Founding Team

DxLab Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2026

    Monthly visitors grew 91% MoM, reaching 2K.

  • Nov 7, 2025

    Monthly visitors increased 246% MoM, from 306 to 1.1K.

DxLab Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DxLab Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DxLab Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSomerville, Massachusetts
Employee Range2
Year Founded2020
Last FundingSep 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.